Segui
Agostinho Lemos
Agostinho Lemos
Affiliazione sconosciuta
Email verificata su uliege.be
Titolo
Citata da
Citata da
Anno
Progress in difluoroalkylation of organic substrates by visible light photoredox catalysis
A Lemos, C Lemaire, A Luxen
Advanced Synthesis & Catalysis 361 (7), 1500-1537, 2019
1662019
Medicinal chemistry strategies to disrupt the p53–MDM2/MDMX interaction
A Lemos, M Leao, J Soares, A Palmeira, M Pinto, L Saraiva, ME Sousa
Medicinal Research Reviews 36 (5), 789-844, 2016
862016
Late‐Stage 18F‐Difluoromethyl Labeling of N‐Heteroaromatics with High Molar Activity for PET Imaging
L Trump, A Lemos, B Lallemand, P Pasau, J Mercier, C Lemaire, A Luxen, ...
Angewandte Chemie 131 (37), 13283-13288, 2019
712019
New inhibitor of the TAp73 interaction with MDM2 and mutant p53 with promising antitumor activity against neuroblastoma
S Gomes, L Raimundo, J Soares, JB Loureiro, M Leao, H Ramos, ...
Cancer letters 446, 90-102, 2019
472019
Newly Synthesized Oxygenated Xanthones as Potential P-Glycoprotein Activators: In Vitro, Ex Vivo, and In Silico Studies
E Martins, V Silva, A Lemos, A Palmeira, P Puthongking, E Sousa, ...
Molecules 24 (4), 707, 2019
322019
Development of a general automated flow photoredox 18F-difluoromethylation of N-heteroaromatics in an AllinOne synthesizer
L Trump, A Lemos, J Jacq, P Pasau, B Lallemand, J Mercier, C Genicot, ...
Organic Process Research & Development 24 (5), 734-744, 2020
282020
Synthesis of a small library of nature-inspired xanthones and study of their antimicrobial activity
DISP Resende, P Pereira-Terra, J Moreira, J Freitas-Silva, A Lemos, ...
Molecules 25 (10), 2405, 2020
262020
Synthesis, Biological Evaluation, and In Silico Studies of Novel Aminated Xanthones as Potential p53-Activating Agents
A Lemos, AS Gomes, JB Loureiro, P Brandão, A Palmeira, MMM Pinto, ...
Molecules 24 (10), 1975, 2019
252019
In silico studies targeting G-protein coupled receptors for drug research against Parkinson's disease.
A Lemos, R Melo, AJ Preto, JG Almeida, IS Moreira, M Cordeiro
Current Neuropharmacology 16 (6), 786-848, 2018
222018
Radical C–H 18F-Difluoromethylation of Heteroarenes with [18F]Difluoromethyl Heteroaryl-Sulfones by Visible Light Photoredox Catalysis
ALP Lemos, L Trump, B Lallemand, P Pasau, J Mercier, C Lemaire, ...
Catalysts 10 (3), 275, 2020
162020
Understanding the binding specificity of G-protein coupled receptors toward G-proteins and arrestins: application to the dopamine receptor family
AJ Preto, CAV Barreto, SJ Baptista, JG Almeida, A Lemos, A Melo, ...
Journal of Chemical Information and Modeling 60 (8), 3969-3984, 2020
152020
Oxygenated xanthones as P-glycoprotein modulators at the intestinal barrier: in vitro and docking studies
V Silva, E Gil-Martins, C Rocha-Pereira, A Lemos, A Palmeira, ...
Medicinal Chemistry Research 29, 1041–1057, 2020
122020
Computational approaches in antibody-drug conjugate optimization for targeted cancer therapy
R Melo, A Lemos, AJ Preto, JG Almeida, JDG Correia, O Sensoy, ...
Current Topics in Medicinal Chemistry 18 (13), 1091-1109, 2018
122018
From natural xanthones to synthetic C-1 aminated 3, 4-dioxygenated xanthones as optimized antifouling agents
DISP Resende, JR Almeida, S Pereira, A Campos, A Lemos, JE Plowman, ...
Marine Drugs 19 (11), 638, 2021
112021
Computer-aided drug design approaches to study key therapeutic targets in Alzheimer’s disease
A Lemos, R Melo, IS Moreira, MNDS Cordeiro
Computational Modeling of Drugs Against Alzheimer’s Disease, 61-106, 2018
62018
An overview of antiretroviral agents for treating HIV infection in paediatric population
R Melo, A Lemos, AJ Preto, B Bueschbell, P Matos-Filipe, C Barreto, ...
Current medicinal chemistry 27 (5), 760-794, 2020
52020
Arrestin and G protein interactions with GPCRs: a structural perspective
CAV Barreto, SJ Baptista, B Bueschbell, PR Magalhães, AJ Preto, ...
GPCRs as Therapeutic Targets 1, 109-179, 2022
42022
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–17